This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Starting and monitoring antidepressant treatment

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Starting and Monitoring antidepressant treatment

When an antidepressant is to be prescribed in routine care, it should be a selective serotonin reuptake inhibitor (SSRI), because SSRIs are as effective as tricyclic antidepressants and are less likely to be discontinued because of side effects.

  • explore any concerns the person has about taking medication and provide information, including:
    • the gradual development of the full antidepressant effect
    • the importance of taking medication as prescribed and the need to continue beyond remission
    • potential side effects and drug interactions
    • the risk and nature of discontinuation symptoms (particularly with drugs with a shorter half-life, such as paroxetine and venlafaxine)
    • the fact that addiction does not occur

  • for people who are not considered to be at increased risk of suicide, normally see them after 2 weeks. See them regularly, for example every 2-4 weeks in the first 3 months, and then at longer intervals if response is good

  • for people who are considered to be at increased risk of suicide or are younger than 30 years, normally see them after 1 week and then frequently until the risk is no longer clinically important

  • if a person experiences side effects early in treatment, provide information and consider:
    • monitoring symptoms closely if side effects are mild and acceptable to the person or
    • stopping or changing to a different antidepressant if the person prefers or
    • in discussion with the person, consider short-term concomitant treatment with a benzodiazepine if anxiety, agitation and/or insomnia are problematic (except in people with chronic symptoms of anxiety); this should usually be for no longer than 2 weeks in order to prevent the development of dependence

  • people who start on low-dose TCAs and have a clear clinical response can be maintained on that dose with careful monitoring

  • If the person's depression shows no improvement after 2 to 4 weeks with the first antidepressant, check that the drug has been taken regularly and in the prescribed dose

  • if response is absent or minimal after 3-4 weeks of treatment with a therapeutic dose of an antidepressant, increase support and consider:
    • increasing the dose in line with the summary of product characteristics (SPC) if there are no significant side effects or
    • switching to another antidepressant if there are side effects or if the person prefers

  • if there is some improvement by 4 weeks, continue treatment for another 2-4 weeks. Consider switching antidepressants if:
    • response is still not adequate or
    • there are side effects or
    • the person prefers to change drug

For more detailed guidance then refer to full NICE guideline (1).

Specific advice if monitoring after switching antidepressant treatment (4):

Advising people

Ensure the person knows the monitoring they can expect after the switch, by whom, and when. Advise people at their review appointment on aspects such as the:

  • time required for treatment to be effective - it may take a minimum of 4 to 6 weeks for the efficacy of the switch to be seen (4)
  • discuss the possibility of side-effects and that discontinuation symptoms may be associated with the switch
    • discontinuation symptoms may include:
      • restlessness
      • trouble sleeping
      • unsteadiness
      • sweating
      • stomach problems
      • feeling as if there’s an electric shock in your head
      • feeling irritable, anxious or confused
  • discuss the risks of serotonin syndrome and symptoms and signs
    • clinical presentation ranges from mild to life-threatening. Possible clinical features include:
      • autonomic dysfunction (tachycardia, blood pressure changes, hyperthermia, sweating, shivering and diarrhoea)
      • neuromuscular hyperactivity (tremor, rigidity, myoclonus, clonus and hyperreflexia)
      • altered mental state (agitation, confusion, mania and coma)
  • risk of relapse, and that medication may be needed for 6 months or longer (if relapse risk is higher) even after remission of symptoms
  • non-addictive nature of antidepressants
  • management of missed or extra doses and the risks associated with stopping an antidepressant
    • patient advice re: missed or extra doses
      • It's important not to miss any of your doses, as this could make your treatment less effective.
      • You may also get withdrawal symptoms as a result of missing a dose of the medicine.
      • If you do miss 1 of your doses, skip the missed dose and take your next dose at the usual time. Do not take a double dose to make up for the dose you missed.
      • If you take more tablets than prescribed, contact your GP or NHS 111 as soon as possible for advice
    • patient advice re:stopping antidepressants
      • Talk to your doctor before you stop taking antidepressants. It's important that you do not stop taking antidepressants suddenly.
      • Once you're ready to come off antidepressants, your doctor will probably recommend reducing your dose gradually over several weeks – or longer, if you have been taking them for a long time.
      • This is to help prevent any withdrawal symptoms you might get as a reaction to coming off the medicine. These include:
        • restlessness
        • trouble sleeping
        • unsteadiness
        • sweating
        • stomach problems
        • feeling as if there's an electric shock in your head
        • feeling irritable, anxious or confused
      • Withdrawal symptoms are often mild and get better on their own. However, some people have withdrawal symptoms that are severe and last for several months or more.
      • Coming off antidepressants too soon can cause your condition to return. Stopping before you have been taking them for 4 weeks may mean the medicine has not had a chance to work.
  • availability of self-help groups, and how and from whom to seek urgent support

Reference:

  1. NICE (April 2018). Depression
  2. Anderson IM et al (2000). Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. J Psychopharmacol, 14, 3-20.
  3. MeReC Briefing (2005); 31:1-8.
  4. NHS Specialist Pharmacy Service (February 2023). Monitoring a person during and after antidepressant switching
  5. NHS Advice (accessed February 21st 2023). Antidepressant treatment - missed doses or stopping treatment

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.